Cytomegalovirus

CMV is a Herpesvirus that can be problematic in immunocompromised individuals and the risk of it being acquired through a transfusion is mitigated through leukocyte-reduced blood and/or by providing CMV-seronegative blood (provided the recipient has not already been exposed).